跳至主要内容
临床试验/NCT06615609
NCT06615609招募中不适用

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 536 人开始时间: 2025年9月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
536
试验地点
1
主要终点
The control rates of hypertension, diabetes and hyperlipidemia

研究概览

简要总结

This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (coronary artery bypass grafting) patients or post-PCI (percutaneous coronary intervention) patients. A randomized controlled trial design will be used, involving approximately 5-10 hospitals and 536 participants. Eligible participants are adults aged 18 or older, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Data manager and statistician.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥ 18 years.
  • •History of CABG surgery or PCI with history of hypertension, diabetes, and dyslipidemia.
  • •At least one of the following criteria is meet:
  • •Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg
  • •HbA1c no less than 7%
  • •LDL-C no less than 1.4 mmol/L
  • •Use of a smartphone.
  • •Signed informed consent.

排除标准

  • •History of heart failure or severe arrhythmias.
  • •Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.
  • •Pregnancy, lactation, or plans for pregnancy within the next year.
  • •Cognitive, communication impairments, or limitations in daily activities.

研究组 & 干预措施

"Smart family doctor" assisted management plus health managers

Experimental

"Smart family doctor", an AI-assisted applications with personalized interactions and 3-hour health management guidance from a health manager once a week.

干预措施: Smart family doctor (Behavioral)

"Smart family doctor" assisted management plus health managers

Experimental

"Smart family doctor", an AI-assisted applications with personalized interactions and 3-hour health management guidance from a health manager once a week.

干预措施: Health manager (Behavioral)

Usual care: health managers

Placebo Comparator

3-hour health management guidance from a health manager once a week.

干预措施: Health manager (Behavioral)

结局指标

主要结局

The control rates of hypertension, diabetes and hyperlipidemia

时间窗: 6-month

All cretria are meet: 1. Systolic blood pressure less than 130 mmHg and diastolic blood pressure less than 80 mmHg. 2. HbA1c less than 7%. 3. LDL-C less than 1.4 mmol/L.

The control rates of hypertension, diabetes and hyperlipidemia

时间窗: 6-month

All cretria are meet: 1. Systolic blood pressure less than 130 mmHg and diastolic blood pressure less than 80 mmHg. 2. HbA1c less than 7%. 3. LDL-C less than 1.4 mmol/L.

次要结局

  • Blood Pressure Control Rate(6-month)
  • Smoking Rate(6-month)
  • Total cholesterol(6-month)
  • HDL-C(6-month)
  • Triglycerides(6-month)
  • Small dense LDL-C(6-month)
  • Lipoprotein (a)(6-month)
  • Fasting blood glucose(6-month)
  • HbA1c(6-month)
  • Physical Activity Level(6-month)
  • Coronary artery disease-related quality of life(6-month)
  • Psychological status(6-month)
  • Cognitive function(6-month)
  • HbA1c(6-month)
  • Blood Pressure Control Rate(6-month)
  • Triglycerides(6-month)
  • Small dense LDL-C(6-month)
  • Lipoprotein (a)(6-month)
  • Fasting blood glucose(6-month)
  • Physical Activity Level(6-month)
  • Quality of life using the Short Form Health Survey (SF-12v2)(6-month)
  • Coronary artery disease-related quality of life(6-month)
  • Psychological status(6-month)
  • Smoking Rate(6-month)
  • Total cholesterol(6-month)
  • LDL-C(6-month)
  • HDL-C(6-month)
  • Cognitive function(6-month)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Xin Yuan

Professor

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验